We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-19.67%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.74B
AUM Growth
-$52.2M
Cap. Flow
+$616M
Cap. Flow %
22.46%
Top 10 Hldgs %
20.88%
Holding
327
New
27
Increased
203
Reduced
54
Closed
34

Top Buys

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$28.8M
2
WW
WW International
WW
+$26.6M
3
WIX icon
WIX.com
WIX
+$21.1M
4
PINC
Premier
PINC
+$20.4M
5
URBN icon
Urban Outfitters
URBN
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 22.84%
2 Industrials 19.01%
3 Technology 16.97%
4 Consumer Discretionary 11%
5 Communication Services 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AJRD
51
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$17.2M 0.63%
+487,645
New +$16.6M
URBN icon
52
Urban Outfitters
URBN
$6.59B
$17M 0.62%
+511,790
New +$19.1M
NUVA
53
DELISTED
NuVasive, Inc.
NUVA
$16.7M 0.61%
336,671
+6,507
+2% +$391K
AERI
54
DELISTED
Aerie Pharmaceuticals
AERI
$16.5M 0.6%
457,505
+179,432
+65% +$8.42M
OMCL icon
55
Omnicell
OMCL
$1.68B
$16.4M 0.6%
267,634
+4,388
+2% +$297K
MRCY icon
56
Mercury Systems
MRCY
$6.52B
$16.3M 0.6%
344,927
+68,659
+25% +$3.35M
SHOO icon
57
Steven Madden
SHOO
$3.55B
$16.1M 0.59%
+533,010
New +$16.4M
LNN icon
58
Lindsay Corp
LNN
$1.18B
$16.1M 0.59%
166,957
+21,308
+15% +$2.08M
COLL icon
59
Collegium Pharmaceutical
COLL
$956M
$16M 0.58%
932,126
+366,184
+65% +$6.27M
OXM icon
60
Oxford Industries
OXM
$552M
$16M 0.58%
225,282
+38,488
+21% +$3.12M
SIX
61
DELISTED
Six Flags Entertainment Corp.
SIX
$15.9M 0.58%
285,750
+76,103
+36% +$4.55M
AZTA icon
62
Azenta
AZTA
$1.48B
$15.8M 0.58%
603,098
+245,075
+68% +$7.16M
FIVE icon
63
Five Below
FIVE
$13.5B
$15.7M 0.57%
153,519
+38,384
+33% +$4.24M
IWO icon
64
iShares Russell 2000 Growth ETF
IWO
$15.1B
$15.7M 0.57%
93,410
+89,004
+2,020% +$16.6M
OPLN
65
Openlane
OPLN
$4.54B
$15.7M 0.57%
868,608
+215,233
+33% +$4.46M
IMAX icon
66
IMAX
IMAX
$2.66B
$15.4M 0.56%
816,925
+379,006
+87% +$7.73M
AIN icon
67
Albany International
AIN
$1.78B
$15.4M 0.56%
245,921
+4,827
+2% +$337K
BSTC
68
DELISTED
BioSpecifics Technologies Corp.
BSTC
$15.2M 0.56%
251,281
+69,591
+38% +$4.16M
GWB
69
DELISTED
Great Western Bancorp, Inc.
GWB
$14.8M 0.54%
474,065
+8,437
+2% +$307K
CMCO icon
70
Columbus McKinnon
CMCO
$584M
$14.7M 0.54%
488,311
+12,512
+3% +$424K
EFOR
71
Everforth Inc
EFOR
$1.32B
$14.2M 0.52%
259,908
+4,872
+2% +$318K
ENSG icon
72
The Ensign Group
ENSG
$10.7B
$14.1M 0.51%
388,075
-141,298
-27% -$5.5M
FLOW
73
DELISTED
SPX FLOW, Inc.
FLOW
$14M 0.51%
460,358
+8,459
+2% +$319K
CBM
74
DELISTED
Cambrex Corporation
CBM
$14M 0.51%
369,617
+65,814
+22% +$3.33M
HAIN icon
75
Hain Celestial
HAIN
$53.7M
$13.8M 0.5%
871,119
+242,371
+39% +$5.4M

Similar funds

Rice Hall James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Rice Hall James & Associates held 327 positions worth $2.74B, down 1.9% from $2.79B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Rice Hall James & Associates deployed $616M of net new capital in Q4 2018, opening 27 new positions and adding to 203 existing holdings. Its largest new stake was Myriad Genetics: 800,553 shares worth $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Coherent, an estimated $12.2M trimmed.

  • Rice Hall James & Associates's largest Q4 2018 buy was Myriad Genetics: 800,553 shares worth $23.3M.
  • Rice Hall James & Associates added most to WW International in Q4 2018, an estimated $26.6M increase.
  • Rice Hall James & Associates's biggest Q4 2018 reduction was Coherent, cutting an estimated $12.2M.
  • Rice Hall James & Associates fully exited Conduent in Q4 2018, selling an estimated $25.1M.
  • Rice Hall James & Associates's ten largest holdings make up 21% of its $2.74B portfolio in Q4 2018.
  • Rice Hall James & Associates opened 27 new positions and closed 34 in Q4 2018.
  • Rice Hall James & Associates's portfolio value fell 1.9% quarter-over-quarter to $2.74B.

Based on Rice Hall James & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.